Viswanath Pilla
Journalist at Moneycontrol
Journalist @moneycontrolcom. Tracks pharma/healthcare. Previously @EconomicTimes @livemint @CNBCTV18Live. Views are personal, RTs are not endorsements.
Articles
-
4 days ago |
flipboard.com | Viswanath Pilla
4 hours agoIndian wildlife photographer Sachin Rai still remembers tigress "Arrowhead" pouncing on a crocodile and tearing away its leathery flesh with her teeth. Mr Rai had been photographing the iconic tigress in western Rajasthan state's Ranthambore national park since she was a cub. Last week, Arrowhead, …
-
3 weeks ago |
flipboard.com | Viswanath Pilla
6 hours agoPresident Trump is doubling down on steel and aluminum tariffs. Starting today, the tax on imported metals is set to jump to 50%, twice what it was yesterday. The president announced the latest trade war offensive Friday, while visiting a US Steel plant outside Pittsburgh. Trump told a crowd of …
-
3 weeks ago |
flipboard.com | Viswanath Pilla
4 hours agoThailand: Popping-off-a-dom! Rival Indian restaurants clash over turf war leaving three injuredBangkok, Thailand - May 29, 2025 This is the shocking moment rival Indian restaurant owners clashed in a turf war in Thailand. The shopkeepers allegedly began fighting when one accused the other of stealing their customers in the lucrative tourist market of Bangkok. CCTV footage shows the rival chefs hurling plastic stools through the windows and damaging signs during the fracas on May 29.
-
2 months ago |
moneycontrol.com | Viswanath Pilla
India's drug regulator plans to bring in specialists from the private sector and even abroad in its expert review committees to evaluate complex modern therapies, a marked departure from its long-standing reliance on government-only experts. Central Drugs Standard Control Organisation (CDSCO) chief Dr Rajeev Singh Raghuvanshi described the move as a "very important milestone" necessary to keep pace with innovation.
-
2 months ago |
moneycontrol.com | Viswanath Pilla
HomeNewsBusinessCompaniesIndian medical device makers prepare for US push, sensing opportunity from China tariffs Trending TopicsRBI Monetary PolicySensex LiveRepo Rate CutIndia GDP GrowthRBI Monetary Policy Highlights Some of the India medical devices companies have started work on regulatory filings and paperwork, to ensure they do not miss out on the opportunity emerging out of this tariff war.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →Coverage map
X (formerly Twitter)
- Followers
- 1K
- Tweets
- 1K
- DMs Open
- Yes
RT @Vikasmakwana111: LIVE CCTV VIDEO CCTV footage of Ahmedabad-London Air India flight taking off #Ahmedabadplanecrash #london #planecra…
RT @moneycontrolcom: Eli Lilly ‘encouraged’ by response to weight-loss drug Mounjaro in India, maps expansion 🇮🇳🚀 Since launching in March…
RT @moneycontrolcom: #Business | Venkat Jasti’s billion-dollar gamble: Can Suven Life crack the CNS drug puzzle? 🏢💊 @viswanath_pilla write…
